跳至主要内容
临床试验/NCT06387472
NCT06387472已完成不适用

Adaptive Deployment of DermAI to Evaluate Human Factor of Testing

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 151 人开始时间: 2024年5月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Mayo Clinic
入组人数
151
试验地点
1
主要终点
Classification of Test Site Region Reaction

研究概览

简要总结

The purpose of this research is to improve how well remote patch allergy testing works and make sure they are easy and practical for people to use from home.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •- Willing and able to provide informed consent.

排除标准

  • •Has used topical or oral steroids two weeks prior to patch testing.
  • •Currently taking immunosuppression agents or is immunocompromised due to medical condition.
  • •No sunburn or rash at site of testing.
  • •Women who are breastfeeding or pregnant.
  • •Treatment with ultraviolet (UV) light (including tanning) during the two weeks prior to visit.
  • •Subjects unable to comply with patch test study requirements including multiple return visits and activity restrictions (e.g., protecting patch test area from excess moisture due to showering).

研究组 & 干预措施

DermAI and Patch Allergen Testing

Experimental

Subjects will have two allergen patches on their forearms for 48 hours. After 48 hours, the patches will be removed and a photograph will be taken where the patches were placed. This photograph will undergo interpretation by a medical professional and by the AI algorithm (DermAI) to evaluate for positive allergic reactions.

干预措施: AI algorithm to evaluate photographs of skin test patch regions (Device)

DermAI and Patch Allergen Testing

Experimental

Subjects will have two allergen patches on their forearms for 48 hours. After 48 hours, the patches will be removed and a photograph will be taken where the patches were placed. This photograph will undergo interpretation by a medical professional and by the AI algorithm (DermAI) to evaluate for positive allergic reactions.

干预措施: Allergen Patch (Device)

结局指标

主要结局

Classification of Test Site Region Reaction

时间窗: 1 week

Number of skin patch interpretations using novel AI algorithms analysis to be in concordant with human review interpretation for the classification of regions within the test panel that either were a reaction (reaction grade 1+) or no reaction (grade 0).

次要结局

  • False Positive Rate(1 week)
  • False Negative Rate(1 week)
  • Classification of Test Site Region Using a 5-point Scale Where Skin Patch Interpretations Were a Grade 0(1 week)
  • Classification of Test Site Region Using a 5-point Scale Where Skin Patch Interpretations Were a Grade 1(1 week)
  • Classification of Test Site Region Using a 5-point Scale Where Skin Patch Interpretations Were a Grade 2(1 week)
  • Early Termination of Testing(1 week)
  • Classification of Test Site Region Using a 5-point Scale Where Skin Patch Interpretations Were a Grade 3(1 week)
  • False Positive Rate(1 week)
  • Classification of Test Site Region Using a 5-point Scale Where Skin Patch Interpretations Were a Grade 4(1 week)
  • False Negative Rate(1 week)
  • Participants That Removed Patches Early(1 week)
  • Adverse Events Related to Allergen Exposure(1 week)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew Hall

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验